BACKGROUND Patients with the metabolic syndrome are more likely to develop type 2 diabetes and may have an increased risk of cardiovascular disease (CVD) events.We aimed to establish whether CVD event rates were influenced by the metabolic syndrome as defined by the World Health Organisation (WHO), the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) and the Int...

Background: Metabolic syndrome (MS) is a cluster of metabolic disturbances, and its prevalence is increasing worldwide. MS exhibits variations among ethnic groups. Zoroastrianism is an ethnic minority which has maintained its isolation and endogamy up to now. So, we evaluated the frequency of MS in Zoroastrians of Yazd, Iran.   Methods: In this cross-sectional study, participants aged &...

background: metabolic syndrome (ms) is a cluster of metabolic disturbances, and its prevalence is increasing worldwide. ms exhibits variations among ethnic groups. zoroastrianism is an ethnic minority which has maintained its isolation and endogamy up to now. so, we evaluated the frequency of ms in zoroastrians of yazd, iran.   methods: in this cross-sectional study, participants aged ≥30 years...

The objective of the study was to examine the differences in gender and age prevalences of metabolic syndrome (MetS) among adult Qatari population according to the revised criteria of NCEP ATP III and IDF, assess which component contributed to the higher prevalence of the MetS and identify the characteristics of the subjects with MetS. The study was designed as a cross-sectional study. The surv...

Background—Inflammation markers and metabolic syndrome (MetS) are associated with risk of congestive heart failure (CHF). We evaluated whether combining inflammation markers and MetS provided additive information for incident CHF and if incorporating inflammation markers to the MetS definition added prognostic information. Methods and Results—We studied 4017 men and women 65 years old, without ...

BACKGROUND Inflammation markers and metabolic syndrome (MetS) are associated with risk of congestive heart failure (CHF). We evaluated whether combining inflammation markers and MetS provided additive information for incident CHF and if incorporating inflammation markers to the MetS definition added prognostic information. METHODS AND RESULTS We studied 4017 men and women > or =65 years old, ...

Background. The objective of this naturalistic study was to evaluate changes in the prevalence of metabolic syndrome (MetS) and Framingham cardiovascular risk scores in adult with schizophrenia after inhospital treatment with antipsychotics. Methods. For 58 patients (36 women and 22 men) the following data was acquired on admission and at discharge: body height and weight, waist circumference, ...